kabutan

StemCell Institute, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term

Tue May 13, 2025 3:30 pm JST Earnings

7096 StemCell Institute 【J-GAAP】

Earnings Report

StemCell Institute <7096> [TSE Growth] announced its financial results after the market closed on May 13th (15:30). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 increased 2.6% from the previous period to 428 million yen. For the fiscal year ending March 2026, the ordinary profit is expected to grow by 5.1% to 450 million yen, marking the third consecutive term of record-high profits. This will be the fifth consecutive term of revenue and profit growth.

At the same time, the company plans to remove the commemorative dividend of the previous term and set the dividend for this term at an ordinary dividend of no dividend.

In the most recent three-month period, from January to March (4Q), the ordinary profit grew 3.4% from the same period last year, reaching 61 million yen. However, the operating profit margin remained almost flat, changing from 9.5% in the same period last year to 9.4%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,091 297 300 198 19.3 0 May 11, 2023 J-GAAP
Mar, 2024 2,481 413 417 310 30.4 0 May 14, 2024 J-GAAP
Mar, 2025 2,679 418 428 385 37.7 25 May 13, 2025 J-GAAP
YoY +8.0% +1.2% +2.6% +24.2% +24.1%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 3,000 600 600 500 48.9 25 May 14, 2024 J-GAAP
Mar, 2025 Results 2,679 418 428 385 37.7 25 May 13, 2025 J-GAAP
Revision Rate -10.7% -30.3% -28.7% -23.0% -22.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 1,373 258 264 271 26.5 25 Nov 12, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,481 413 417 310 30.4 0 May 14, 2024 J-GAAP
Mar, 2025 2,679 418 428 385 37.7 25 May 13, 2025 J-GAAP
Mar, 2026 Guidance 3,000 450 450 320 31.8 0 May 13, 2025 J-GAAP
YoY +12.0% +7.7% +5.1% -16.9% -15.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 597 57 59 56 5.5 9.5 May 14, 2024 J-GAAP
Apr - Jun, 2024 678 123 124 178 17.4 18.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 695 135 140 93 9.1 19.4 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 667 100 103 68 6.7 15.0 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 639 60 61 46 4.5 9.4 May 13, 2025 J-GAAP
YoY +7.0% +5.3% +3.4% -17.9% -17.9%

Related Articles